302 related articles for article (PubMed ID: 15053246)
1. Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism?
Orio F; Palomba S; Cascella T; Tauchmanovà L; Di Biase S; Labella D; Russo T; Pellicano M; Savastano S; Zullo F; Lombardi G; Colao A
J Endocrinol Invest; 2004 Jan; 27(1):61-6. PubMed ID: 15053246
[TBL] [Abstract][Full Text] [Related]
2. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
3. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin.
van Hooff MH; Voorhorst FJ; Kaptein MB; Hirasing RA; Koppenaal C; Schoemaker J
Fertil Steril; 2000 Jul; 74(1):49-58. PubMed ID: 10899496
[TBL] [Abstract][Full Text] [Related]
5. Detection of functional ovarian hyperandrogenism in women with androgen excess.
Ehrmann DA; Rosenfield RL; Barnes RB; Brigell DF; Sheikh Z
N Engl J Med; 1992 Jul; 327(3):157-62. PubMed ID: 1319000
[TBL] [Abstract][Full Text] [Related]
6. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovaries and associated clinical and biochemical features among women with infertility in a tertiary hospital in Tanzania.
Pembe AB; Abeid MS
Tanzan J Health Res; 2009 Oct; 11(4):175-80. PubMed ID: 20734696
[TBL] [Abstract][Full Text] [Related]
8. Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluation.
Colonna L; Pacifico V; Lello S; Sorge R; Raskovic D; Primavera G
J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1364-71. PubMed ID: 22011217
[TBL] [Abstract][Full Text] [Related]
9. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
Bidzińska B; Tworowska U; Demissie M; Milewicz A
Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
[TBL] [Abstract][Full Text] [Related]
10. Hormone profile & polycystic ovaries in acne vulgaris.
Jebraili R; Kaur S; Kanwar AJ; Kataria S; Dash RJ
Indian J Med Res; 1994 Aug; 100():73-6. PubMed ID: 7927560
[TBL] [Abstract][Full Text] [Related]
11. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
Franks S; Layton A; Glasier A
Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
[TBL] [Abstract][Full Text] [Related]
12. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
[TBL] [Abstract][Full Text] [Related]
13. [Androgens in the plasma of women with hirsutism (author's transl)].
Demisch K; Magnet W; Neubauer M; Schöffling K
Dtsch Med Wochenschr; 1975 May; 100(20):1117-23. PubMed ID: 123849
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome.
Falsetti L; Gambera A; Tisi G
Hum Reprod; 2001 Jan; 16(1):36-42. PubMed ID: 11139533
[TBL] [Abstract][Full Text] [Related]
15. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).
De Leo V; la Marca A; Lanzetta D; Cariello PL; D'Antona D; Morgante G
Clin Endocrinol (Oxf); 1998 Jul; 49(1):85-9. PubMed ID: 9797851
[TBL] [Abstract][Full Text] [Related]
16. SHBG, testosterone, androstenedione, 17-OH-Progesterone plasma levels in PCO affected women treated with a triphasic oral contraceptive.
Negri P; Agnello G; Borghesani F; Tomain L; Minisci N; D'Errico G; Cavallini AR
Acta Eur Fertil; 1987; 18(6):375-80. PubMed ID: 3454501
[TBL] [Abstract][Full Text] [Related]
17. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.
Carmina E; Rosato F; Jannì A; Rizzo M; Longo RA
J Clin Endocrinol Metab; 2006 Jan; 91(1):2-6. PubMed ID: 16263820
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
Lobo RA; Goebelsmann U; Horton R
J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
[TBL] [Abstract][Full Text] [Related]
19. Hyperandrogenism caused by a rare adrenocortical oncocytic neoplasm with uncertain malignant potential: a case report and review of the literature.
Bao Z; He W; Di W; Gao H
Endocr J; 2023 Mar; 70(3):275-280. PubMed ID: 36384706
[TBL] [Abstract][Full Text] [Related]
20. Adolescent menstrual irregularity.
Mansfield MJ; Emans SJ
J Reprod Med; 1984 Jun; 29(6):399-410. PubMed ID: 6379175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
